News
Pharmaceutical Technology on MSN6d
Novartis concludes Regulus Therapeutics acquisitionThe transaction was approved by both companies' boards and includes a significant premium over recent stock prices for ...
New research by Sumeda Nandadasa, PhD, reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...
One of the leading causes of kidney disease in non-diabetics is high blood pressure, also called hypertension. The kidneys ...
Jim FessendenUMass Chan Medical SchoolNew research by Sumeda Nandadasa, PhD, reveals how a key protein associated with Meckel-Gruber syndrome ...
Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also stave off dementia?
6don MSN
As Canada launches its new disability benefit payments in July, medical and disability experts are raising alarms over ...
AZoLifeSciences on MSN2d
Study Finds Protein Cleavage Essential for Healthy Cilia and Cell SignalingNew research by Sumeda Nandadasa, PhD, reveals how a key protein associated with Meckel-Gruber syndrome, nephronophthisis, ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.
India Today on MSN5d
Endocrinologist Dr. Ambrish Mithal on the happy side-effects of weight-loss drugsNew GLP-1 weight-loss drugs are changing obesity treatment in India with promising health benefits. Dr. Ambrish Mithal, India's top endocrinologist, in an episode of Booked, highlights the impact of ...
Novel research presented at the 41st annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback